Tumor Necrosis Rate Adjusted by Tumor Volume Change Is a Better Predictor of Survival of Localized Osteosarcoma Patients
Explore this paper's citation graph
Summary
The necrosis rate adjusted by the tumor volume change is an independent prognostic factor in osteosarcoma and may serve as a basis for risk-adapted therapy in combination with other prognostic factors.
- Type
- article
- Published
- 2008-03-01
- Cited by
- 57
- References
- 36
- OpenAlex
- https://openalex.org/W18163171
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:40184275
Keywords
Mental health, Psychology, Health promotion, Promotion (chess), Environmental health
References
- Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
- A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma.
- Tumor size and prognosis in aggressively treated osteosarcoma.
- Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
- Tumor Volume Change as a Predictor of Chemotherapeutic Response in Osteosarcoma
- Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing’s sarcoma: review of current imaging modalities
- Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy?
- Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumor
- Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapy
- Osteosarcoma: chemotherapy-induced changes at MR imaging.
- Increased survival, limb preservation, and prognostic factors for osteosarcoma
- The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.
- Use of99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy
- Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging.
- Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
- Can conventional radiographs be used to monitor the effect of neoadjuvant chemotherapy in patients with osteogenic sarcoma?
- Morphological grades of regression in osteosarcoma after polychemotherapy — Study COSS 80
- Survival Data for 648 Patients with Osteosarcoma Treated at One Institution
- Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment
- Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience
Cited by
- Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis
- Comparative effectiveness in thyroid cancer: key questions and how to answer them.
- Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18 F-FDG PET/CT and MRI
- Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma
- 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis.
- Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice
- The significance of size change of soft tissue sarcoma during preoperative radiotherapy.
- Variables Involved in Measuring Cancer Response to Treatment.
- Time-efficient sparse analysis of histopathological whole slide images
- How can survival be improved in localized osteosarcoma?
- Osteosarcoma: improvement in survival limited to high-grade patients only
- Growth patterns of osteosarcoma predict patient survival
- Distal Radius Osteosarcoma
- Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma
- Combination of 18F-FDG PET/CT and Diffusion-Weighted MR Imaging as a Predictor of Histologic Response to Neoadjuvant Chemotherapy: Preliminary Results in Osteosarcoma
- Differential Presentations, Clinical Courses, and Survivals of Osteosarcomas of the Proximal Humerus over Other Extremity Locations
- Prognostic factors in canine appendicular osteosarcoma – a meta-analysis
- Pediatric osteogenic sarcoma
- An examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdivision of AJCC stage II osteosarcoma patients
- Noninvasive Assessment of Response to Neoadjuvant Chemotherapy in Osteosarcoma of Long Bones with Diffusion-Weighted Imaging: An Initial In Vivo Study
Related papers
- The prognosis of common mental disorders in adolescents: a 14-year prospective cohort study (vol 383, pg 1404, 2014)
- GENDER INEQUALITY IN THE LABELING OF BEHAVIOR AS MENTAL-ILLNESS - THE CASE OF THE PREMENSTRUAL-SYNDROME
- VITAMIN-B6 AND PMS - PRELIMINARY-REPORT OF STUDIES RELATING DEPRESSION TO FUNCTIONAL B6 ACTIVITY AND HORMONE LEVELS IN PLASMA